Catalyst Wire Dossier Catalyst Wire Dossier

IRay Plus

· Oraya Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IRay Plus, covering 2014-12-05 to 2014-12-05. Get the full timeline:

Most recent: Clinical Trial Update: INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD [Phase 2]

See pricing